Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -12.05 | N/A |
| PEG Ratio (TTM) | 0.35 | N/A |
| P/S Ratio (TTM) | 2,656.29 | N/A |
| P/B Ratio (TTM) | 11.55 | N/A |
| P/FCF Ratio (TTM) | -28.01 | N/A |
| Price to 5YR AVG Earnings Ratio | -23.14 | N/A |
| Price to 5YR AVG FCF Ratio | -49.25 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -36.04% | N/A |
| ROE (TTM) | -165.06% | N/A |
| Net Profit Margin (TTM) | -11,846.08% | N/A |
| ROIC 5YR AVG | -1,431.23% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -60.66% | -16,824.04% | -10,092.37% |
| Revenue | 25.56% | 242.36% | 162.92% |
| Net Income | -82.52% | -304.04% | -187.56% |
| Cash Flow | -25.71% | -862.54% | -535.64% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 5.80 | N/A |
| Quick Ratio (TTM) | 5.80 | N/A |
| D/E Ratio (TTM) | 0.66 | N/A |
| Interest Coverage (TTM) | -54.91 | N/A |
| Piotroski F-Score | 1 | N/A |
| Altman Z-Score | 11.22 | N/A |
| LTL to 5YR AVG FCF | -0.53 | N/A |
| Shares Outstanding Growth 5YR AVG | 7.12% | N/A |